RE: barcode/CarbonRythman,
Just to be clear, I dont know any "secret" about the "Mechanism of Action".... I just know there is one !
I actually read about this whole "mechanism of action" (MOA)issue in Paradigm's recent report. Camire specifically said in his report that PLI was disclosing the MOA at the ASH conference. I dont know whether they did or not.
I had never heard about this before, so last week I specifically asked management what the big deal was about this. The basic explanation I got was that they think the drug acts on a specific and novel "receptor" unrelated to that of EPO. I get the impression that disclosing the mechanism receptor is a really big deal in the industry. If I understand correctly, its a big deal because the specific receptor hasnt previously been linked to Red Blood cell production or dealing with Renal Failure..... If I understand correctly, the company's contention is that this is very relevant to big Pharma, because it will lead to exploration of other ways to stimulate this receptor for other indications...
Beyond that... the discussion is over my head.
By the way, I completely agree with the criticism over the lack of exposure over this whole conference so far. This just seemed like a great opportunity for the company to get both awareness within the industry, as well as mileage and publicity in the market. This is a very frustrating and long process. Why arent they on BNN, CNBC ? Why isnt there any mention in the Business pages ?
I frankly also think it was a kick in the teeth to get a financing announcement on the same weekend we were expecting to get good press and increased awareness post presentation As much as I like the whole LOC concept and the fact that this seemingly deals with the company's cash well into 08 , I would have rather had big positive publicity or some related positive announcements...